Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles.
about
Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross-talk act as a linchpin in the events leading to thromboinflammation.Complement activation turnover on surfaces of nanoparticles.Non-specific adsorption of complement proteins affects complement activation pathways of gold nanomaterials.Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11b/CD18.
P2860
Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mediation of a non-proteolytic ...... t C3 by phospholipid vesicles.
@ast
Mediation of a non-proteolytic ...... t C3 by phospholipid vesicles.
@en
type
label
Mediation of a non-proteolytic ...... t C3 by phospholipid vesicles.
@ast
Mediation of a non-proteolytic ...... t C3 by phospholipid vesicles.
@en
prefLabel
Mediation of a non-proteolytic ...... t C3 by phospholipid vesicles.
@ast
Mediation of a non-proteolytic ...... t C3 by phospholipid vesicles.
@en
P2093
P2860
P50
P1433
P1476
Mediation of a non-proteolytic ...... nt C3 by phospholipid vesicles
@en
P2093
Daniel Ricklin
Gero Leneweit
Kristina N Ekdahl
Osama A Hamad
Yuji Teramura
Yvonne Klapper
P2860
P304
P356
10.1016/J.BIOMATERIALS.2013.12.085
P577
2014-01-23T00:00:00Z